Global Neurovascular Stents Market Size By Type (Carotid Artery Stents, Intracranial Stents), By Application (Hospital And Clinic, Medical Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Neurovascular Stents Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.6 billion by 2031, expanding at a CAGR of 10.1% during the forecast period from 2023 to 2031. This growth is primarily driven by the increasing incidence of ischemic strokes, rising geriatric population, and growing adoption of minimally invasive neurovascular procedures. Neurovascular stents are crucial in the treatment of cerebral aneurysms and intracranial stenosis, offering a safe and effective solution for restoring cerebral blood flow and preventing secondary strokes.

Drivers:

1. Rising Prevalence of Ischemic Stroke:

The global burden of ischemic strokes is increasing significantly, particularly in aging populations. As neurovascular stents play a vital role in the management of stroke-related blockages, their demand is expected to escalate accordingly.

2. Technological Advancements in Stent Design:

Next-generation stents with enhanced flexibility, visibility, and biocompatibility are boosting clinical outcomes, thereby encouraging their adoption. Innovations such as flow diverters and dual-layer stents are revolutionizing neurointerventional procedures.

3. Increasing Adoption of Minimally Invasive Procedures:

Minimally invasive endovascular techniques using neurovascular stents are preferred due to reduced recovery time, minimal trauma, and shorter hospital stays, all contributing to increased market penetration.

Restraints:

1. High Cost of Neurovascular Procedures:

The high cost associated with stent-based neurointerventions and related imaging technologies can limit access, especially in low- and middle-income countries.

2. Risk of Complications:

Despite advancements, risks such as in-stent restenosis, thrombosis, and hemorrhagic events remain a concern and may restrain broader market adoption.

Opportunity:

1. Expansion into Emerging Markets:

Rapid improvements in healthcare infrastructure and increasing government investments in countries like India, Brazil, and China present lucrative growth opportunities for neurovascular stent manufacturers.

2. Strategic Collaborations and Clinical Trials:

Ongoing collaborations between medical device companies and clinical research institutions are expected to accelerate product innovation and regulatory approvals, expanding the global footprint of neurovascular stents.

Market by System Type Insights:

Among system types, self-expanding stents accounted for the largest market share in 2023. Their flexibility and adaptability to the tortuous anatomy of cerebral vessels make them the preferred choice in endovascular procedures. However, balloon-expandable stents are projected to register the fastest growth, driven by advancements in hybrid stent platforms and their growing use in specific neurovascular conditions.

Market by End-Use Insights:

The hospitals segment dominated the market in 2023, contributing to over 60% of total revenue, due to the availability of advanced neurointerventional equipment and specialized medical personnel. Ambulatory surgical centers (ASCs) are expected to gain momentum, offering same-day procedures with cost advantages and increasing adoption of outpatient neurovascular care.

Market by Regional Insights:

North America led the global neurovascular stents market in 2023, supported by advanced healthcare infrastructure, high prevalence of stroke, and favorable reimbursement policies. The Asia-Pacific region is projected to experience the highest CAGR during the forecast period, fueled by an aging population, rising stroke cases, and increased healthcare spending in countries like China, Japan, and India.

Competitive Scenario:

Leading players in the Global Neurovascular Stents Market include Stryker Corporation, Medtronic plc, MicroVention Inc. (Terumo Corporation), Balt USA LLC, Abbott Laboratories, and Penumbra Inc. These companies are focusing on geographic expansion, product launches, and regulatory approvals. Notable developments include:

2024: Stryker launched a next-gen self-expanding neurovascular stent with integrated radiopaque markers for enhanced visibility.

2023: Medtronic received FDA approval for its new flow-diverter stent designed for complex wide-neck aneurysms.

2022: MicroVention expanded its manufacturing facility in California to meet growing global demand for neurovascular devices.

Scope of Work – Global Neurovascular Stents Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 4.6 billion

CAGR (2023–2031) 10.1%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rising stroke incidence, Minimally invasive procedures, Technological advancements

Opportunities Expansion into emerging markets, Clinical research collaborations

Key Market Developments:

April 2024: Balt USA launched an ultra-low profile neurovascular stent system targeting distal intracranial stenosis.

December 2023: Penumbra entered into a partnership with an AI imaging startup to improve preoperative planning for stent placements.

June 2023: Abbott Laboratories reported a 20% year-over-year growth in neurovascular device sales driven by strong global demand.

FAQs:

1) What is the current market size of the Global Neurovascular Stents Market?

The market size was valued at USD 2.1 billion in 2023.

2) What is the major growth driver of the Global Neurovascular Stents Market?

The increasing prevalence of ischemic stroke and rising adoption of minimally invasive neurointerventional procedures are key growth drivers.

3) Which is the largest region during the forecast period in the Global Neurovascular Stents Market?

North America holds the largest share, while Asia-Pacific is the fastest-growing region.

4) Which segment accounted for the largest market sha